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Inﬂuenza A and B viruses are responsible for the severe morbidity and mortality worldwide in annual
inﬂuenza epidemics. Currently circulating inﬂuenza B virus belongs to the B/Victoria or B/Yamagata
lineage that was diverged from each other about 30–40 years ago. However, a mechanistic understanding
of their divergent evolution is still lacking. Here we report the crystal structures of inﬂuenza B/
Yamanashi/166/1998 hemagglutinin (HA) belonging to B/Yamagata lineage and its complex with the
avian-like receptor analogue. Comparison of these structures with those of undiverged and diverged
inﬂuenza B virus HAs, in conjunction with sequence analysis, reveals the molecular basis for the
divergent evolution of inﬂuenza B virus HAs. Furthermore, HAs of diverged inﬂuenza B virus strains
display much stronger molecular interactions with terminal sialic acid of bound receptors, which may
allow for a different tissue tropism for current inﬂuenza B viruses, for which further investigation is
required.
& 2013 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza A and B viruses of the Orthomyxoviridae family are
responsible for seasonal inﬂuenza epidemics with severe morbidity
and mortality worldwide (Palese and Shaw, 2007; Taubenberger and
Morens, 2008; Wright et al., 2007). Annual inﬂuenza vaccine has been
conventionally used to reduce human suffering and economic burden
caused by the viruses. However, the constant genetic and antigenic
changes of inﬂuenza viruses render them the ability to evade host
immune system (Nelson and Holmes, 2007), thus limiting the vaccine
effectiveness.
Inﬂuenza B virus was ﬁrst isolated in 1940 and has diverged
into two genetically and antigenically distinct lineages since 1983
or earlier (Chen et al., 2007; Shen et al., 2009): the B/Victoria
lineage represented by the reference strain B/Victoria/2/87, and
the B/Yamagata lineage represented by the B/Yamagata/16/88
strain, respectively (Kanegae et al., 1990; Rota et al., 1990; Shaw
et al., 2002). The B/Victoria lineage predominated during the
1980s, while the B/Yamagata lineage predominated in most part
of the world during the 1990s (Lin et al., 2004). The B/Victoria
lineage re-emerged in Europe and United States in 2001, and the
two lineages have co-circulated ever since (Ikonen et al., 2005;
Shaw et al., 2002).ll rights reserved.As one of the two major surface glycoproteins of inﬂuenza virus,
hemagglutinin (HA) mediates host entry of the virus and is a primary
target for host neutralizing antibodies (Han and Marasco, 2011). The
precursor of HA, HA0, is synthesized as a single-stranded polypeptide,
which is then cleaved into two disulﬁde-bonded subunits: HA1 and
HA2 (Copeland et al., 1986). HA1 contains the receptor-binding site and
harbors the majority of antigenic sites that undergo constant antigenic
variations (Knossow and Skehel, 2006). On the other hand, HA2, which
contains the fusion peptide at its N-terminus and is responsible for
inducing fusion of viral envelope and endosomal membrane, is the
most conserved (Vareckova et al., 2003). In an infection, HA ﬁrst binds
to the sialic-acid receptors on the host cell surface, thus triggering the
internalization of the virus by endocytosis (Matlin et al., 1981; Skehel
and Wiley, 2000). The low-pH environment in the late endosome
results in the protonation of multiple negative charged residues
located at the HA1–HA1 and HA1–HA2 interfaces, thereby dissociating
HA1 and HA2 (Korte et al., 2007; Rachakonda et al., 2007; Wang et al.,
2008). The subsequent large-scale conformational change in HA2
(Bullough et al., 1994; Chen et al., 1999) fuses the viral and endosomal
membranes and allows the delivery of viral genetic materials into
cellular cytosol.
The determination of the ﬁrst crystal structure of the ectodo-
main of inﬂuenza virus B/Hongkong/8/1973 (B/HK/73) HA has
allowed the mapping of its antigenic structure (Wang et al.,
2008). There are four major epitopes on the membrane-distal
globular domain of inﬂuenza B virus HA: the 120-loop (HA1116–
137), the 150-loop (HA1141–150), the 160-loop (HA1162–167), and
Table 1
Data collection and reﬁnement statistics.
B/Yamanashi/98 HA B/Yamamashi/98 HA-LSTa
Data collection statistics
Resolution range (Å) 43.6–3.54 (3.73–3.54) 39.37–2.50 (2.64–2.50)
Space group C 1 2 1 C 1 2 1
Unit cell
a, b, c (Å) 174.9, 101.3, 136.8 176.1, 101.5, 137.4
α, β, γ (1) 90, 115.2, 90 90, 115.2, 90
Unique reﬂections 26,547 75,849
Multiplicity 3.8 (3.8) 3.8 (3.8)
Completeness (%) 99.98 (100.00) 99.99 (100.00)
Mean I/sigma(I) 10.6 (2.3) 11.7 (2.3)
Wilson B-factor (Å2) 109.1 46.7
Rmerge (%) 9.8 (49.7) 9.1 (49.4)
Reﬁnement statistics
Rcryst (%) 19.8 (27.2) 18.8 (26.2)
Rfree (%) 24.4 (30.9) 22.4 (32.0)
Number of atoms 12,115 12,754
Protein 11,695 11,695
Ligands 420 588
Water 0 471
RMSD bond length (Å)/bond angle (1) 0.004/1.03 0.007/0.87
Ramachandran plot
Favored, allowed, disallowed (%) 96.3, 3.6, 0.1 96.5, 3.4, 0.1
Average B-factor (Å2) 120.6 50.3
Statistics for the highest-resolution shell are shown in parentheses. The coordinates and structure factors of B/Yamanashi/98
HA and B/Yamanashi/98 HA-LSTa have been deposited into Protein Data Bank under accession codes of 4M40 and 4M44,
respectively.
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regions. All these four epitopes have been demonstrated to be
under positive selective pressure in the course of evolution (Nunes
et al., 2008; Pechirra et al., 2005; Shen et al., 2009). However, the
mechanism by which amino-acid substitutions change the anti-
genic property of HA remains elusive.
Here we report the crystal structure of inﬂuenza B/Yamanashi/
166/1998 (B/Yamanashi/98) HA determined to 3.54-Å resolution
(Table 1), a strain belonging to the B/Yamagata lineage. Together
with the recently determined structure of inﬂuenza B/Brisbane/60/
2008 (B/Brisbane/08) HA (B/Victoria lineage) and the complex
structure of the membrane-distal globular domain of inﬂuenza B/
Florida/4/2006 (B/Florida/06) HA (B/Yamagata lineage) in the
region of HA133–324 with its antibody (Dreyfus et al., 2012), we
performed a systematic structural comparison to characterize the
evolution of HA antigenicity at the molecular level. In addition, we
have also determined the crystal structure of B/Yamanashi/98 HA
in complex with avian-like receptor analogue to 2.50-Å resolution.
This, in comparison with the structure of B/HK/73 HA complexed
with avian-like receptor analogue (Wang et al., 2007), reveals that
the diverged inﬂuenza B virus HAs have developed a distinct and
much more efﬁcient receptor-binding site than early strains.Results
The overall structure of B/Yamanashi/98 HA
The structure of unliganded B/Yamanashi/HA is determined to
3.54-Å resolution (Table 1). There is one HA trimer in an asym-
metric unit (Fig. 1a). Each subunit of B/Yamanashi/98 HA has
the same seven disulﬁde bridges as found in B/HK/73 HA
(Wang et al., 2008): Cys41–Cys1372, Cys541–Cys571, Cys601–
Cys721, Cys941–Cys1431, Cys1781–Cys2721, Cys2921–Cys3181 and
Cys1442–Cys1482 (Fig. 1b).
B/Yamanashi/98 HA has nine predicted glycosylation sites (six
on HA1: 25, 59, 145, 163, 301, 330; and three on HA2: 145, 171, and
184) on each subunit. All glycans are built in the ﬁnal structure(Fig. 1a and b) with the exception of HA2171 for which no clear
density is observed and HA2184 that was not present in the
construct used for crystallization. The glycosylation at HA1145
that ﬁrst appeared in B/Great Lakes/54 HA has been maintained up
to today. On the other hand, the glycosylation at HA1123 as found
in B/HK/73 HA (Wang et al., 2008) is completely abolished in HAs
of both B/Victoria and B/Yamagata lineages due to the predomi-
nant presence of Ile-125 instead of Thr-125 (Table 2). It is not clear
why the glycosylation site at HA1123 is so short-lived. One
explanation is that since the 120-loop is a strong epitope of
inﬂuenza B virus HA, different mutational strategies have been
used to evade recognition by host immunity. The glycosylation site
at HA1123 in B/HK/73 is just one such strategy and did not get
populated in subsequent inﬂuenza B virus strains. However, the
majority of B/Victoria lineage strains have established a new
glycosylation site at HA1230, which is present in 50% of early
inﬂuenza B virus strains, and not present in the majority of B/
Yamagata lineage strains (Table 2).
Similar to B/HK/73 HA (Wang et al., 2008), the fusion peptide of
B/Yamanashi/98 HA located at the N-terminus of HA2 points away
from its own helix A and helix B to interact with those of a
neighbouring subunit instead (Fig. 1c).Antigenic structure of inﬂuenza B virus HAs
Known inﬂuenza B virus HA structures are of B/HK/73 repre-
senting undiverged early strains (PDB codes: 3BT6, 2RFT and
2RFU) (Wang et al., 2008, 2007), B/Brisbane/08 representing
the B/Victoria lineage (PDB code: 4FQM) (Dreyfus et al., 2012),
B/Florida/06 (in the region of HA133–324, PDB code: 4FQJ)
(Dreyfus et al., 2012) and B/Yamanashi/98 belonging to the B/
Yamagata lineage. We performed a structure-based analysis of the
divergent evolution of these HAs. Since the B/Florida/06 HA is in
complex with human monoclonal antibody CR8071 in the region
of residues HA137–41, 52–62, 85–90, and 282–287 (Dreyfus et al.,
2012), we will ignore the structural variations in these regions in
the following comparison.
Fig. 1. Structure of B/Yamanashi/98 HA. (a) Ribbon diagram of B/Yamanashi/98 HA structure with three subunits differently colored (grey, blue and green). The receptor-
binding site (RBS) is highlighted in red color. Glycans resolved in the crystal structure are also shown. (b) Structure of a B/Yamanashi/98 HA subunit. HA1 and HA2 are in
yellow and green color, respectively. The two major helices on HA2, helix A and helix B, are also labelled. Disulﬁde bonds on each subunit are shown as space-ﬁlling models in
purple, and seven sugar residues are in ball-and-stick models. The RBS is labelled in red. (c) Comparison of the fusion peptide between B/Yamanashi/98 HA and inﬂuenza
A/H3 virus HA (PDB code: 3HMG). The helix A and helix B and fusion peptide from each subunit are shown in different colors: green, blue and grey for B/Yamanashi/98 HA,
and red, yellow and cyan for inﬂuenza A/H3 virus HA. It is clear that the fusion peptide of B/Yamanashi/98 HA points away from its helix A and helix B and interacts with the
helices from a neighbouring subunit. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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each other. However, regions with large structural variations,
expressed as Cα-root-mean-square differences (Cα-RMSDs), are
observed when using the unliganded structure of B/HK/73 HA as a
reference (PDB code: 3BT6) (Fig. 2a–f). For instance, there exhibitlarge structural differences between B/Brisbane/08 and B/HK/73 HAs
in the regions of the 120-loop (including residues at or around
HA159, 75, 121, 180, 284), 150-loop (at around HA1146), 160-loop (at
around HA1163) and 190-helix (at around HA1238) (Fig. 2a and b).
Moreover, large structural variations are observed between
Table 2
Frequent amino-acid substitutions in inﬂuenza B virus HAs.
Residues at site a HA (1972–1982, six sequences) HA (Victoria, 278 sequences) HA (Yamagata, 282 sequences)
120-Loop
48 50% Q, 50% K 75% E, 22% K 58% R, 41% K
56 100% N 95% K, 1% D 65% D, 20% T, 12% N
71 100% K 98% K, 1% M 99% M
75 83% T, 16% N 47% K, 46% N, 3% T 75% T, 18% I, 3% V
116 100% N 94% H, 2% R, 2% N 73% N, 22% K, 3% H
122 100% R 97% H, 1% Q 94% Q, 5% H
125 66% I, 33% T 99% I 99% I
129 50% R, 50% T 75% N, 21% K, 2% T 89% K, 7% R, 3% N
179–181 100% TKG 97% TEG 60% TEG, 21% TKE, 11% TKG
150-Loop
148–150 100% NGN 96% NGN, 2% NGI, 1% SKI 47% SKS, 28% SKI, 20% SRS, 1% SRD
160-Loop
Insertion at 162–163 – 51% NDK, 42% NDN, 3% NEN 88% DN, 9%D, 1%GN, 1% EN
190-Helix
195 83% E, 17% A 97% E, 2% K 98% K
199 100% V 94% A, 3% V 99% K
206 100% K 97% K, 1% N 99% N
230 100% N 97% N, 1% D 87% D, 7% N, 3% A
232 50% T, 50% A 94% T, 4% A 98% T, 1% K
235 50% E, 50% G 100% G 99% G
RBS
136 100% I 97% K, 1% R 98% R, 1% K
HA2
132 83% D, 16% E 97% E, 2% D 88% D, 11% E
158 100% N 89% D, 10% N 98% N, 1% D
a The residues are numbered according to that of B/HK/73 HA.
Fig. 2. Comparison of known inﬂuenza B virus HA structures. Pairwise structural comparison ((a), (c), (e) and (g)) and the corresponding Cα-RMSD ((b), (d), (f) and (h)).
The pairs are: (a) and (b) B/Brisbane/08 and B/HK/73 HAs in the range of HA133–324; ((c) and (d)). B/Yamanashi/98 and B/HK/73 HAs in the range of HA133–324; (e) and
(f) B/Florida/06 and B/HK/73 HAs in the range of HA191–281; (g) and (h) B/Yamanashi/98 and B/Yamanashi/98-LSTa HAs in the range of HA133–324.
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121, 180, 284), 150-loop (at around HA1149), 160-loop (at around
HA1163) and 190-helix (at around HA1238) (Fig. 2c and d). Similarly,
B/Florida/06 and B/HK/73 HAs have large structural changes in all
these four regions (Fig. 2e and f). Interestingly, the structural
differences in the 150-loop region of B/Yamagata lineage HAs
(Fig. 2c–f) are much larger than that of B/Victoria lineage (Fig. 2a
and b), consistent with the observation that the 150-loop regionappears to be a particularly strong neutralizing epitope for B/
Yamagata lineage strains in recent isolates (Nakagawa et al., 2003;
Shen et al., 2009). The overall RMSD in the region of HA191–281 of
HAs of recent strains compared to B/HK/73 HA is in the range of
0.840–0.874 Å for Cα-atoms only and 0.917–0.950 Å for main-chain
atoms (Table 3).
We also compared the structures of B/Yamanashi/98 HA and its
complex with avian-like receptor analogue LSTa (Fig. 2g and h).
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atoms only and 0.213 Å for main-chain atoms (Table 3). Although
the two structures are highly similar, relatively large structural
differences are still observed in regions of the 120-loop (at around
HA159, 71), 150-loop (at around HA1145), 160-loop (at around
HA1163), and 190-helix (at around HA1196 and 237 (Fig. 2g and h).
Among these regions, only the 190-helix is directly in contact with
bound receptor analogue. Therefore, the structure of inﬂuenza B
virus HA is intrinsically ﬂexible in regions of 120-loop, 150-loop,
160-loop and 190-helix regardless of bound receptors.
Previous studies have assigned four major epitopes on the
structure of B/HK/73 HA: the 120-loop, 150-loop, 160-loop and
190-helix and their respective surrounding regions (Berton et al.,
1984; Berton and Webster, 1985; Hovanec and Air, 1984; Rivera
et al., 1995; Wang et al., 2008; Webster and Berton, 1981). Analysis
of 278 HA sequences from B/Victoria lineage and 282 HA
sequences from B/Yamagata lineage revealed that amino-acid
substitutions in the sequences are concentrated on these four
epitope regions (Table 2). The high amino-acid substitution fre-
quency and the large structural variations of these regions are
probably inter-connected: the high structural ﬂexibility of theseTable 3
RMSD of known inﬂuenza B virus HA structures in the region of residues
HA191–281.
RMSD (Å) B/
Brisbane/
08 vs. B/
HK/73
B/
Yamana-
shi/98 vs.
B/HK/73
B/Florida/
06 vs. B/
HK/73
B/Yamanashi/
98 vs. B/
Yamanashi/
98-LSTa
Cα atoms 0.874 0.840 0.854 0.214
Main-chain
atoms
0.917 0.948 0.950 0.213
Fig. 3. Antigenic structure of inﬂuenza B virus HA. (a) Surface presentation of the globul
B/Yamanashi/98 or B/Brisbane/08 relative to B/HK/73 HA (Cα-RMSD greater than 1.0 Å) a
green, 160-loop in blue and 190-helix region in red). (b)–(e) Amino-acid substitutions
(yellow) for the 120-loop region (b), 150-loop (c), 160-loop (d) and 190-helix region (e
referred to the web version of this article.)regions makes them easily accommodate drifting mutations with-
out compromising the structural integrity of inﬂuenza B virus HA,
and the drifting mutations introduced therein could easily cause
structural changes that are large enough to evade recognition by
neutralizing antibodies.The 120-loop and its surrounding regions
The 120-loop and its surrounding regions have some of the
largest deviations from the structure of B/HK/73 HA (Fig. 3a). For
instance, the average Cα-RMSD from B/HK/73 HA for the region of
HA151–54, 56–59, 73–75, 121–123, 129, 137 is 0.96 Å and 1.29 Å for
B/Yamanashi/98 and B/Brisbane/08 HAs, respectively. Since some
of these regions in B/Florida/06 HA are involved in binding to the
antibody, we omitted the comparison between B/Florida/06 and B/
HK/73 HAs. However, the fact that these regions serve as antibody
binding site itself conﬁrms their contribution to the antigenicity of
inﬂuenza BHA. As expected, these regions harbor sites that
undergo constant amino-acid substitutions (Fig. 3b, Table 2) and
are identiﬁed to be under positive selection in previous phyloge-
netic and antigenic studies, such as HA156, 73, 75, 122, 129, 137
(Nunes et al., 2008; Shen et al., 2009). Overall, the B/Yamagata
lineage strains are closer to the early inﬂuenza B strains in terms of
both structure and residue types in this region (Table 2).
HA1179–181 in the vestigial esterase domain belongs to the
120-loop epitope (Fig. 3b). This region has the motif of 179TKG181 in
early inﬂuenza B strains (1972–1982) including B/HK/73 (Table 2).
However, this motif is changed to 179TEG181 in 97% of B/Victoria
strains. In sharp contrast, in B/Yamagata lineage, the motif of
179TKG181 is kept only in 11% strains, while 60% strains including
B/Florida/06 strain have 179TEG181 motif, and 21% strains including
B/Yamanashi/98 strain acquire a new 179TKE181 motif (Table 2).
The 179TEG181 in B/Florida/06 and in B/Brisbane/08 has a similarar domain of B/Yamanashi/98 HA. Residues with large structural variations between
re highlighted based on their spatial location (120-loop region in cyan, 150-loop in
in B/Brisbane/08 HA (purple), B/Yamanashi/98 HA (green) relative to B/HK/73 HA
). (For interpretation of the references to color in this ﬁgure legend, the reader is
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However, the 179TKE181 motif as found in B/Yamanashi/98 strain
has a much larger Cα-RMSD (at 2.27 Å) from B/HK/73 HA.
Apparently, the residues in the vicinity of HA1179–181 in the
vestigial esterase domain are under much stronger diversifying
selective pressure in the B/Yamagata lineage than in the B/Victoria
lineage. From a structural point of view, HA1179–181 in B/Yama-
nashi/98 HA is more protruding than in the structure of B/
Brisbane/08 HA (Fig. 3b), resulting in 270 Å2 more exposed surface
area in each trimer (from a total solvent accessible surface area of
855 Å2 in B/Brisbane/08 HA to 1,125 Å2 in B/Yamanashi/98 HA),
equivalent to an increase from 58% of total solvent accessible
surface area to 67%.
Relative to B/HK/73 HA, B/Yamanashi/98 and B/Brisbane HAs
have Cα-RMSDs of 1.21 Å and 1.10 Å in the region of HA1283–285,
respectively. This region belongs to the 120-loop and is part of the
epitope that binds to human monoclonal antibody CR8071 in the
complex with B/Florida/06 HA (Dreyfus et al., 2012).
The 150-loop
The 150-loop is a long protruding loop in which single amino-
acid substitutions are frequently found to cause altered antigenic
properties (Abed et al., 2003; Berton et al., 1984; Berton and
Webster, 1985; Hovanec and Air, 1984; Lugovtsev et al., 2007;
Nakagawa et al., 2003). The motif of 148NGN150 is conserved in
early inﬂuenza B strains and in 96% of B/Victoria lineage strains,
whereas in B/Yamagata lineage, the motifs of 148SKS150, 148SKI150
and 148SRS150 are found in 47%, 28% and 20% inﬂuenza B virus HAs,
respectively (Fig. 3c, Table 2). Thus, the 150-loop is likely under
strong diversifying selective pressure in B/Yamagata lineage (Shen
et al., 2009), which is responsible for the signiﬁcantly larger
structural differences than those of B/Victoria lineage as observed
in Fig. 2a–f. For instance, for the residues in the range of HA1
139–142 and 145–151 where large structural differences are
noticed relative to B/HK/73 HA, B/Yamanashi/98 and B/Florida/06
HAs (B/Yamagata lineage) have an average Cα-RMSD of 1.65 Å
and 1.81 Å, respectively, which is 1.30 Å for B/Brisbane/06 HA
(B/Victoria lineage).
The 160-loop
The 160-loop is located at the membrane-distal “tip” of the HA
molecule. This is the only region where insertions and deletions
are frequently found (Hovanec and Air, 1984; McCullers et al.,
1999; Nerome et al., 1998) (Table 2). Comparing with B/HK/73 HA
that has the shortest 160-loop, both B/Victoria and B/Yamagata
strains have insertions in this region. Relative to the reference
B/Victoria/2/87 strain that has a NDN insertion between residues
HA1162 and 163, 42% B/Victoria HA sequences have the same motif
while 51% sequences including B/Brisbane/08 strain have a NDK
insertion instead (Table 2). In contrast, relative to the reference
B/Yamagata/16/88 strain that has a single D insertion between
residues HA1162 and 163, only 9% HA sequences of 282 recent
B/Yamagata strains keep this insertion, 88% sequences including
those of B/Yamanashi/98 and B/Florida/06 have a DN insertion and
the rest 3% sequences have other two-residue insertions (Fig. 3d,
Table 2). The average Cα-RMSD in the region of HA1162–165
relative to B/HK/73 HA is 1.01 Å, 1.51 Å and 1.35 Å (excluding the
inserted residues labeled as 163A, B, C in Fig. 3d) for B/Yamanashi/
98, B/Florida/06 and B/Brisbane/08 HA, respectively. Therefore,
although the 160-loop epitope was once thought to be speciﬁc for
B/Victoria lineage in antigenic drift (Nakagawa et al., 2001;
Nakagawa et al., 2005), the recent B/Yamagata lineage has
reclaimed this loop as an epitope.The 190-helix and its surrounding regions
The 190-helix region (including the 190-helix and 240-loop) is
located at the membrane-distal end of the HA molecule and
constitutes the top- and left-edge of the receptor-binding site
(Fig. 3a). The 190-helix is constantly under strong positive selec-
tive pressure in both B/Victoria and B/Yamagata lineages (Nunes
et al., 2008; Pechirra et al., 2005; Shen et al., 2009). Two residues
in the 190-helix have large structural differences from B/HK/73
HA: HA1194 and HA1206 (Fig. 3a). The average Cα-RMSD for these
two residues from that of B/HK/73 HA are 0.46 Å, 0.65 Å and 1.05 Å
for B/Yamanashi/98, B/Florida/06 (B/Yamagata lineage)
and B/Brisbane/08 (B/Victoria lineage), respectively. In addition,
frequent amino-acid substitutions are found in three positions:
HA1195, 199 and 200 (Table 2, Fig. 3e). The average Cα-RMSD
at these sites with B/HK/73 HA is 0.33 Å, 0.40 Å and 0.58 Å for
B/Yamanashi/98, B/Florida/06 (B/Yamagata lineage) and B/Brisbane/
08 (B/Victoria lineage), respectively. Therefore, B/Victoria HA is
apparently more diverged from B/HK/73 HA in this region (Fig. 3e).
The region of HA1235–240 has the largest Cα-RMSD of all from
B/HK/73 HA: at 2.23–2.34 Å for B/Yamanashi/98, B/Florida/06 and
B/Brisbane/08 HAs (Fig. 3a), as the result of a large structural
rearrangement in this region (Fig. 3e). The residue Glu-235 in B/
HK/73 HA is changed to Gly-235 in 100% B/Victoria lineage and
99% B/Yamagata lineage strains (Table 2). The presence of Gly-235
results in a more extended 240-loop and causes one-residue shift
in side-chain orientation (Fig. 3e). For example, the side chain of
Pro-238 in B/Yamanashi/98, and B/Brisbane/08 HA structures is
placed at a similar location to that of Leu-237 in B/HK/73 HA
(Fig. 3e). Consequently, the side chain of Gln-239 in all other
inﬂuenza B virus HA structures is at the same location as that of
Pro-238 in B/HK/73 HA, pointing towards the receptor-binding site
(Fig. 3e). The re-orientation of the side-chains in the region of
HA1235–240 could profoundly change the antigenic properties of
this region.
The receptor-binding site and the B/Yamanashi/98 HA-LSTa complex
The receptor-binding site of inﬂuenza B virus HA is located at
the top of the membrane-distal domain (Fig. 1) formed by 190-
helix, 140-loop and 240-loop (Wang et al., 2007). Its base is
constituted by four absolutely conserved residues: Phe-95, Trp-
158, His-191 and Tyr-202 (Fig. 4a). In B/HK/73 HA (Wang et al.,
2007), besides π-stacking interactions among these aromatic
residues, there are three additional hydrogen bonds that help
stabilize the receptor-binding site: between Tyr-202 and His-191,
Ser-140 and Trp-158, Pro-238 and Ser-240 (Fig. 4a). In B/Yamana-
shi/98 HA, the π-stacking interactions are conserved. Although a
rotation of the side chain of Trp-158 results in the loss of the
hydrogen bond between Ser-140 and Trp-158, a new hydrogen
bond between Trp-158 and Tyr-202 is observed. Moreover, the
large structural rearrangement in the 240-loop as described above
causes the loss of the interaction between Pro-238 and Ser-240,
but a hydrogen bond is gained between the side chain of Gln-239
and Ser-140 instead (Fig. 4a). Overall, similar π-stacking interac-
tions and the same number of hydrogen bonds are observed in the
receptor-binding site of both B/HK/73 and B/Yamanashi/98 HAs.
In the complex structure of B/Yamanashi/98 HA-LSTa, Sia-1,
Gal-2, GlcNAc-3 and Gal-4 are clearly visible (Fig. 4c). The Sia-1
moiety makes extensive hydrogen bonding interactions within the
receptor-binding site of B/Yamanashi/98 HA (Fig. 4c, Table 4),
including one by the main-chain amide of Gly-141, one by each
of the side-chains of Ser-140, Asp-193 and Ser-240. These four
hydrogen bonds were also observed between LSTa and B/HK/73
HA (Table 4). In addition, B/Yamanashi/98 HA makes ﬁve more
hydrogen bonds that were not observed in B/HK/73 HA: two
Fig. 4. Receptor binding of inﬂuenza B virus HA. (a) Comparison of receptor-binding sites between B/Yamanashi/98 (green) and B/HK/73 (grey) HAs. Important residues are
highlighted according to the atom types with the exception that carbon atoms are colored in yellow for B/HK/73 HA and in cyan for B/Yamanashi/98 HA. (b) Comparison of
receptor-binding sites between B/Yamanashi/98 (green) and B/Brisbane/08 (purple) HAs. Important residues are highlighted according to the atom types with the exception
that carbon atoms are colored in cyan for B/Yamanashi/98 HA and in purple for B/Brisbane/08 HA. (c) Molecular interactions between B/Yamanashi/98 HA and avian-like
receptor analogue LSTa. Dashed lines are for hydrogen bonds listed in Table 4. (d) Comparison of LSTa in the receptor-binding sites of B/Yamanashi/98 and B/HK/73 HAs. The
coloring scheme is the same as in (a). (e) Crystal contacts around the LSTa ligand in the structure of B/Yamanashi/98 HA. Two neighboring HA molecules are shown in green
and light grey, and their bound LSTa in cyan and grey, respectively. It is clear that in this conformation, LSTa does not have crystal clashes. (f) Crystal contracts around the
LSTa ligand in the structure of B/Yamanashi/98 HA if LSTa were in a conformation as found in B/HK/73 HA. It is clear that LSTa in this conformation will have steric clashes,
providing an explanation why LSTa adopts the unusual conformation as found in B/Yamanashi/98 HA-LSTa. Coloring scheme is the same as in (e). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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hydrogen bond by the side chain of Arg-136, and two hydrogen
bonds by the side chain of Gln-239 (Fig. 4c, Table 4).
The additional hydrogen bonds with Thr-139 are apparently
due to the fact that the bound Sia-1 moiety of LSTa sits 0.9 Å
lower in the receptor-binding site, thus is closer to the region of
HA1139–141 in B/Yamanashi/98 HA structure (Fig. 4d). Due to the
1.2 Å left shift of the region HA1139–141 at the lower edge of the
receptor-binding site of B/Yamanashi/98 HA in relation to B/HK/73HA, the bound Sia-1 moiety of LSTa is also left-shifted by a similar
distance.
The new hydrogen bond with HA1136 is made possible by the
substitution of Ile-136-Arg (Fig. 4a). This substitution is found in
HA sequences of 98% B/Yamagata strains and 1% B/Victoria strains
(Table 2). However, a similar substitution of Ile-136-Lys is found
in BHA sequences of 1% B/Yamagata strains and 97% B/Victoria
strains. The side chains of Arg-136 in the structure of B/Yamana-
shi/98 HA and Lys-136 in the structure of B/Brisbane/08 HA are
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between the side-chain of Arg-136 and bound Sia-1 moiety is
expected to be present in all these B/Yamagata and B/Victoria strains.
The additional two hydrogen bonds with the side chain of Gln-
239 are made possible as the consequence of the large structural
rearrangement in the 240-loop due to the presence of Gly-235
(Fig. 4a). This new conformation of the 240-loop is shared among
B/Yamanashi/98 and B/Brisbane/08 HA structures (Fig. 4b) and the
residue Gly-235 is observed in 100% of B/Victoria lineage and 99%
of B/Yamagata lineage strains (Table 2). Therefore, the hydrogen
bonding interactions by the side-chain of Gln-239 are preserved in
almost all of recent inﬂuenza B virus HAs.Fig. 5. The Lys206-Asn mutation of HAs in B/Yamagata lineage. (a) The stabilization of t
shown as dashed lines with the distances labeled. The coloring scheme is the same as in
at the HA1–HA1 interface in B/Yamanashi/98 HA structure. Residues Lys-209 and His-2
stabilizing force. Three HA subunits are colored as green, blue and light grey, respective
and standard deviations from at least three independent measurements. (e) pH-depen
deviations from at least three independent measurements. (f) Comparison of the rate of
are averaged values and standard deviations from at least three independent measureme
referred to the web version of this article.)
Table 4
Hydrogen bonding interactions of B/HK/73 and B/Yamanashi/98 HAs with bound
avian-like receptor analogue LSTa.
LSTa Interaction pair B/HK/73
distance (Å)
B/Yamanashi/98
distance (Å)
Sia-1 O1A……Gly-141 N 2.9 2.7
O1B……Ser-140 OG 2.8 2.9
O9………Asp-193 OD2 2.9 2.6
O9………Ser-240 OG 2.4 3.1
O4………Thr-139 O – 3.4
N5………Thr-139 O – 3.2
O1B……Gln-239 NE2 – 2.9
O8………Gln-239 OE1 – 3.1
O10……Arg-136 NH2 – 2.9
Gal-2 O6………Leu-237 O 2.5 –
O6………Pro-238 O – 2.9
GlcNAc-3 O7………Gln-197 NE2 3.4 –
Glc-5 O6………Thr-196 OG1 2.6 –
Hydrogen bonds were identiﬁed by PyMol.Altogether, these ﬁve new hydrogen bonds observed between
B/Yamanashi/98 HA and the Sia-1 moiety of bound LSTa receptor
analogue are expected to be preserved in HAs of almost all of
currently circulating inﬂuenza B virus strains with both human-
like and avian-like receptors that share the Sia-1 moiety. The much
stronger binding between Sia-1 and HAs of these inﬂuenza B
viruses of both lineages is indicative of higher receptor-binding
afﬁnity. The impact of the enhanced receptor-binding afﬁnity on
the pathogenesis and tissue tropism of the virus requires further
investigation.
Moreover, Gal-2 of bound LSTa forms one hydrogen bond with the
main-chain carbonyl atom of Pro-238 in B/Yamanashi/98 HA, while in
the case of B/HK/73 HA, there was one hydrogen bond with the main-
chain carbonyl atom of Leu-237 instead. The GlcNAc-3 and Gal-4
moieties of LSTa do not interact with the receptor-binding site of B/
Yamanashi/98 HA. This is in sharp contrast to the hydrogen bonding
interactions between GlcNAc-3 and the side chain of Gln-197, and
between Glc-5 and the side chain of Thr-196 of B/HK/73 HA (Table 4).
This difference is mainly due to the different binding mode of LSTa in
the receptor-binding sites of B/HK/73 and B/Yamanashi/98 HAs
(Fig. 4d). In B/HK/73 HA, the Gal-4 and Glc-5 point upwards and
interact with the 190-helix, while in B/Yamanashi/98 HA, the Gal-4 lies
above the 240-loop due to the 901 rotation of GlcNAc-3 (Fig. 4d). The
unusual conformation of GlcNAc-3 and Gal-4 of LSTa in B/Yamanashi/
98 HA is probably the result of limited space at near the receptor-
binding site in the crystal lattice (Fig. 4e). If they were adopting the
same conformation as found in B/HK/73 HA, Gal-4 and Glc-5 would
have steric clashes with those of a symmetry-relatedmolecule (Fig. 4f).
The fact that LSTa has similar conformations in all three subunits of B/
Yamanashi/98 HA in an asymmetric unit with strong electron densities
suggests that this is probably one of its most stable conformations. In
sharp contrast, the binding of human receptor analogue LSTc ishe HA1–HA1 interface by three new hydrogen bonds between Asn-206 and Asn-168
Fig. 3. (b) Zoom-in of the hydrogen bond between Subunits B and C. (c) The residues
20 interact with each other at the 3-fold axis of the structure and are the major
ly. (d) pH-dependent hemolysis of B/Brisbane/08 virus. Shown are averaged values
dent hemolysis of B/Yamanashi/98 virus. Shown are averaged values and standard
hemolysis between B/Brisbane/08 virus and B/Yamanashi/98 virus at pH 4.8. Shown
nts. (For interpretation of the references to color in this ﬁgure legend, the reader is
F. Ni et al. / Virology 446 (2013) 112–122120apparently in conﬂict with the existing crystal packing of B/Yamana-
shi/98 HA, thus decreasing the resolution to 4–8 Å.
The HA1–HA1 interface
One of the large structural differences on the 190-helix is
observed at HA1206 (Fig. 5a–c). In both B/HK/73 and B/Brisbane/
08 HA structures, the side chain of residue Lys-206 points towards
or a little away from the three-fold axis. However, this residue
becomes Asn-206 in B/Yamanashi/98 HA that points towards
neighboring HA1 subunits to form strong hydrogen bonds with a
neighboring Asn-168 (Fig. 5a and b). The total of three strong
hydrogen bonds between Asn-206 and Asn-168 for a trimeric
B/Yamanashi/98 HA may help stabilize the neutral-pH HA struc-
ture. However, this stabilizing effect is expected to be marginal to
the overall stability of B/Yamanashi/98 HA as the HA1–HA1 inter-
face is predominantly stabilized by the interactions among three
highly-conserved Lys-209 and His-220 at close to the three-fold
axis (Fig. 5c).
To explore the impact of the new hydrogen bonds by Asn-206 on
the structure and stability of inﬂuenza B virus HAs experimentally, B/
Brisbane/08 and B/Yamanashi/98 viruses were used to study pH-
dependent hemolysis and rate of hemolysis at a given pH. The pH-
dependent hemolysis reﬂects howmany protons are needed to induce
the conformational changes of HA that include: (1) dissociation of
HA1–HA1 interfaces; (2) dissociation of HA1–HA2 interfaces; and (3)
unfolding and refolding of HA2. (2) and (3) are similar for B/Brisbane/
08 and B/Yamanashi/98 strains. For (1), due to the presence of
conserved Lys-209 and His-220 common to both strains, the difference
in pH at which hemolysis starts would reﬂect the contribution of the
new hydrogen bonds by Asn-206. The fact that signiﬁcant hemolysis
were similarly observed for both strains when pH was lower than 5.6
(Fig. 5d and e) suggests that the impact of the new hydrogen bonds by
Asn-206 is not predominant. The rate of hemolysis at a given pH
reﬂects how fast the conformational changes of HA could happen
when sufﬁcient protons exist. By ﬁtting the data to ﬁrst order reaction,
we obtained the reaction rate of 0.05970.007min1 and
0.05070.005 min1 for B/Brisbane/08 and B/Yamanashi/98 strains,
respectively. The about 20% faster reaction rate for B/Brisbane/08
strain than B/Yamanashi/98 strain indicates that the conformational
changes of HA in the former is somewhat easier than the latter, which
has been further stabilized by the new hydrogen bonds formed by
Asn-206. Its impact on the pathogenesis of B/Yamanashi/98 virus
needs to be separately evaluated.
Ionizable residue clusters
Structural analysis of B/HK/73 HA has revealed ionizable residue
clusters that are strategically placed at all regions where structural
rearrangement is expected when HA is exposed to low pH (Wang
et al., 2008). Presumably due to their importance in low-pH-induced
membrane fusion that is crucial for successful host invasion by
inﬂuenza virus, all the ionizable residue clusters identiﬁed in the
previous study (Wang et al., 2008) are well maintained.
Amino-acid substitutions on HA2
Between the B/Victoria and B/Yamagata lineages, amino-acid
substitutions are observed on HA2 at positions 132 and 158
(Table 2). At HA2132, the changes are between negatively charged
residues Glu and Asp, and no large structural difference is
noticed due to this mutation. The residue Asn at HA2158 in early
inﬂuenza B virus strains is kept in 98% of B/Yamagata lineage
strains, but is changed to Asp-158 in 89% of B/Victoria lineage
strains (Table 2). The negative charge at HA2158 in most of B/
Victoria lineage strains might affect the conformation ofmembrane-proximal linker and transmembrane trimer packing
of HAs (Kordyukova et al., 2011).Discussion
The two currently co-circulating lineages of inﬂuenza B viruses
diverged from the early strains in 1983 or earlier (Chen et al.,
2007; Shen et al., 2009). Comparison among the HA structures of
representative inﬂuenza B virus strains before and after the
divergence together with the sequence analysis provides a struc-
tural basis for the divergent evolution of inﬂuenza B virus over the
past several decades.
Antigenic structure of inﬂuenza B virus HA
Through a combined systematic structural and sequence ana-
lysis of HA of inﬂuenza B virus before and after its divergence into
two distinct lineages: B/Victoria and B/Yamagata, we found that
the largest structural variations among different BHAs are strongly
correlated with frequent amino-acid substitutions concentrated at
the four major epitopes. Having predominantly loop structures in
these four major epitopes makes it possible to easily accommodate
amino-acid substitutions that result in structural changes large
enough to evade recognition by neutralizing antibodies, but still
sufﬁciently small to maintain the structural integrity of the
protein, particularly of the receptor-binding site to ensure efﬁcient
binding of cell surface receptors.
Moreover, among the four major epitopes of inﬂuenza B virus
HAs, the 120-loop, 150-loop, 160-loop and 190-helix regions,
differential selective pressures appear to operate on B/Victoria
and B/Yamagata lineage strains. For instance, 150-loop appears to
be under stronger positive selective pressure in the B/Yamagata
lineage than in the B/Victoria lineage. On the other hand, the 160-
loop that used to be speciﬁc for the B/Victoria lineage is now also
being used by the B/Yamagata lineage in recent years. Further-
more, the close spatial locations of the 150-loop, 160-loop and
190-helix, the facts that neutralizing antibodies recognizing the
150- and 160-loops, and the 190-helix compete with each other
(Berton and Webster, 1985; Hovanec and Air, 1984) and that they
all interact with the human monoclonal antibody CR8033 (Dreyfus
et al., 2012) suggest that they most likely constitute a large
continuous antigenic site. On the other hand, the lack of cross-
reactivity between the antibodies recognizing the 120-loop region
and the 160-loop/190-helix (Berton and Webster, 1985; Hovanec
and Air, 1984) and the fact that the footprint of the antibody
CR8071 is solely on the 120-loop (Dreyfus et al., 2012) suggest that
the 120-loop is a separate antigenic site.
Receptor binding of inﬂuenza B virus HA
The receptor-binding activity of HA is one of the key factors of
the pathogenesis of inﬂuenza viruses (Matrosovich et al., 2000;
Rogers and Paulson, 1983; Viswanathan et al., 2010). There are two
most noticeable changes in the receptor-binding site of HA from
recent inﬂuenza B virus isolates.
First, recent HAs of both lineages acquired a long-chain basic
residue at HA1136 (Arg or Lys) (Table 2). The side-chain of Arg-136
in B/Yamanashi/98 HA contributes one hydrogen bond to the Sia-1
moiety of bound LSTa receptor analogue (Fig. 4c). The side-chain of
Lys-136 in unliganded B/Brisbane/08 HA is similarly located in the
receptor-binding site (Fig. 4b), suggesting that both Arg-136
(predominant in B/Yamagata HA) and Lys-136 (predominant in
B/Victoria HA) will likely make similar hydrogen bonding interac-
tions with Sia-1 of bound human or avian-like receptor analogues.
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consequence of the Glu-235 to Gly-235 mutation in both B/
Victoria and B/Yamagata lineages. The structural shift causes re-
orientation of the residues on the 240-loop, despite the overall
high sequence identity in this region among all inﬂuenza B virus
HAs. For instance, Gln-239 in B/Yamanashi/98 HA is ﬂipped over to
interact with the bound receptors. Therefore, current inﬂuenza B
virus of both lineages has evolved a receptor-binding site that is
distinct from that of the early strains, and capable of binding the
Sia-1 moiety of both human and avian-like receptors with a much
higher afﬁnity than B/HK/73 HA (Table 4). A stronger binding of
receptors might allow for a different tissue tropism, for which
further investigation is required.
HA1–HA1 interface of B/Yamagata HAs
The Lys206-Asn mutation of HAs in B/Yamagata lineage
introduces three new strong hydrogen bonds between neighbor-
ing subunits of HA1 (Fig. 5). This results in a slight decrease in the
rate of hemolysis at a given pH, suggesting a small but noticeable
contribution to the overall stability of the neutral-pH structure of
HAs of B/Yamgata lineage.Materials and methods
Protein expression and crystallization
The sequence of B/Yamanashi/98 HA (GI: 125663100) was
retrieved from NCBI gene bank (Benson et al., 2012) and the gene
corresponding to its ectodomain (HA11–342–HA21–176) was
assembled from oligonucleotides according to the previously pub-
lished protocol (Stemmer et al., 1995) and inserted into the pRB21
plasmid containing a trimerizing sequence from the bacteriophage T4
ﬁbritin (foldon) (Stevens et al., 2004) and a His6-tag at the extreme C-
terminus. The ectodomain of B/Yamanashi/98 HA was expressed by
using vaccinia virus system as previously reported (Blasco and Moss,
1995). Brieﬂy, CV-1 monolayers were ﬁrst infected with vaccinia virus
that lacks the vp37 gene at an MOI of 2.0 for 4 h at 37 1C in a CO2
incubator. The pRB21 plasmid containing the B/Yamanashi/98 HA gene
was transfected into the CV-1 cells by Lipofectamine 2000 according
to the manufacture′s instruction (Invitrogen). The cells were further
incubated for 4 h at 37 1C. The supernatant was changed to Dulbecco′s
modiﬁed eagle medium with 10% fetal bovine serum and further
incubated for 40 h. The infected cells that contain recombinant
vaccinia viruses were harvested and lysed by three freeze-and-thaw
cycles in ice/ethanol and 37 1C water bath. The recombinant viruses
were selected based on their ability to produce large plaques. The
plaques were further ampliﬁed in CV-1 cells. For expression,
CV-1 cells were infected with recombinant vaccinia viruses at an
MOI of 1.0 for 40 h. The media of infected CV-1 cells were cleared by
centrifugation and dialyzed overnight against the buffer containing
10 mM Tris–HCl (pH 7.2), 100 mM NaCl, and loaded onto the Cobalt
resin (Thermo Scientiﬁc). The ectodomain of B/Yamanashi/98 HA
protein was released from the beads by trypsin digestion (Sigma).
The protein was subjected to anion-exchange (mono-Q 4.6/100 PE, GE
Healthcare) and gel-ﬁltration (Superdex 200 10/300 GL, GE Health-
care) chromatography. The peak corresponding to trimeric HA was
collected and concentrated to about 25 mg/mL. Crystals were grown
by hanging drop vapor diffusion method in reservoir solution of 0.1 M
Tris–HCl (pH 8.5), 0.2 M Tri-methylamine N-oxide, 23% PEG 2000
MME at 290 K. A ﬁnal concentration of 15% glycerol was included in
the reservoir solution as the cryoprotectant. In order to get structures
of B/Yamanashi/98 HA with sialic-acid receptor analogues, the crystals
were soaked in 16 mM avian-like receptor analogue LSTa or human-
like receptor analogue LSTc (Sigma) for 2 h. The soaking of theB/Yamanashi/98 HA crystals with LSTa increased the resolution to
2.50 Å, while in contrast, the soaking with human-like receptor LSTc
decreased the resolution to about 4–8 Å, possibly due to the damage
to crystal lattice upon the binding of LSTc.Structure determination and model building
The diffraction data were indexed and integrated by using
MOSFLM (Leslie, 2006; Powell, 1999), scaled by SCALA, and
truncated to structure factor amplitude by TRUNCATE in CCP4
(Collaborative Computational Project, 1994). Five percent of
unique reﬂections were randomly chosen as the test set for
calculating the Rfree-factors. The unliganded B/HK/73 HA structure
(Protein Data Bank (PDB) code: 3BT6) (Wang et al., 2008) was used
as the search model for molecular replacement and three copies of
HA1/HA2 monomer was found by AutoMR module implemented in
PHENIX (Adams et al., 2010). The model was re-built by AutoBuild
module and reﬁned by Reﬁnement module in PHENIX (Adams
et al., 2010). The model and map were checked in COOT for further
manual adjustment (Emsley and Cowtan, 2004). Figures for
structural snapshots were generated by PyMOL.Sequence analysis
The full-length inﬂuenza B virus HA protein sequences were
analyzed in NCBI ﬂu database (Bao et al., 2008). 573 unique
sequences from the year 1940 to 2012 were aligned. The phylo-
genetic tree was generated by neighbor-joining method (Fig. S1).
Three clades were selected in the tree: the early inﬂuenza B strains
from 1972 to 1982 (six sequences); the B/Victoria lineage (278
sequences); and the B/Yamagata lineage (282 sequences). The
amino-acid residue substitution frequency in each of three clades
was calculated by Jalview (Waterhouse et al., 2009) (Table 2).Hemolysis assay
The B/Brisbane/08 and B/Yamanashi/98 viruses were provided
by Centers for Disease Control and Prevention (Atlanta, GA). The
pH-dependent hemolysis assay was performed as previously
reported (Maeda and Ohnishi, 1980; Sato et al., 1983). Brieﬂy, the
viruses were mixed with human erythrocytes on ice for 1 h. The
erythrocytes that were bound with viruses were pelleted by
centrifugation and resuspended in 100 mM citrate buffer at
different pH. The reaction was incubated at 37 1C for 1 h and the
supernatant was used to record the absorbance at 540 nm. For the
time-course of hemolysis assay, the virus-erythrocyte suspension
was incubated in citrate buffer at pH 4.8. The sample was taken at
different time points and a pre-determined volume of NaOH was
immediately added to bring the buffer pH to about 7.0. All the
assays were performed at least three times.Acknowledgments
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